Evaluation of Wound Management With Negative Pressure Dressing Versus Standard Dressing After Revision Arthroplasty.
Primary Purpose
Prosthesis-related Infections, Wound Complications, Joint Diseases
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Prevena
Sponsored by
About this trial
This is an interventional treatment trial for Prosthesis-related Infections focused on measuring Revision total knee arthroplasty, Revision total hip arthroplasty, Negative pressure wound therapy system (NPWT), Drainage
Eligibility Criteria
Inclusion Criteria:
- Scheduled revision Total Hip or Knee Arthroplasty Procedure
- Presence of one of the following: body mass index (BMI) greater than 35, use of blood thinners other than acetylsalicylic acid (ASA) after surgery, peripheral vascular disease, depression, diabetes mellitus, current tobacco use, history of prior infection, current use of immunomodulators or steroids, current history of cancer or hematological malignancy, rheumatoid arthritis, renal failure or dialysis, malnutrition, liver disease, transplant status, or HIV.
Exclusion Criteria:
- Patient lives >100 miles from hospital
- Patient is < 18 years old
- Silver allergy
Sites / Locations
- Cleveland Clinic
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
No Intervention
Arm Label
Prevena
Control
Arm Description
Prevena NPWT system will be used immediately following surgery and continue postoperatively until hospital discharge (expected average of 4 days).
A standard of care sterile wound dressing will be placed.
Outcomes
Primary Outcome Measures
Number of Patients With Wound Complications
Any wound complications including but not limited to drainage, blisters, cellulitis, superficial infection, and deep infection.
Re-operation Rates
Number of patients who required re-operations that were related to the revision arthroplasty and occurred within 90 days of the revision
Readmission Rates
Number of patients who had hospital readmission(s) related to the revision surgery that occurred within 90 days of revision
Secondary Outcome Measures
Knee Flexion
Mean knee flexion (degrees) at 4 weeks postoperatively
HOOS and KOOS Scores at 90 Days Postoperatively
Mean Hip Osteoarthritis Outcome Score (HOOS), Knee Osteoarthritis Outcomes Score (KOOS) at 90 days postoperatively. Presented as subscores, including activities of daily living (ADL), pain, quality of life (QOL), symptoms, sports and recreation. All subscores range from 0-100, with 0 being the worst score and 100 being the best possible score.
Timed-up-and-go Test
Median Timed-up-and-go test (seconds)
Hip Range of Motion (Flexion)
Mean hip range of motion (flexion, in degrees) at 4 weeks postoperatively
VR-12 Questionnaire
Mean VR-12 scores, presented as 2 composite scores physical component summary (PCS) and mental component summary (MCS). Physical Component Score (PCS): Provides greater emphasis on questions about general health, physical functioning and role playing and bodily pain. Mental Component Score (MCS): Provides greater emphasis on questions about role-emotional, vitality/mental health and social functioning. PCS and MCS summary scores are standardized using a z-score transformation and normed to a U.S. population (based on a 1990 norm) of a score of 50 and a standard deviation of 10. Higher MCS and PCS scores reflect better overall physical and mental health, respectively.
Hip Range of Motion
Median hip range of motion (extension, in degrees) at 4 weeks postoperatively
Knee Extension
Median knee extension (degrees) at 4 weeks postoperatively
Full Information
NCT ID
NCT02127281
First Posted
April 29, 2014
Last Updated
August 21, 2018
Sponsor
The Cleveland Clinic
Collaborators
3M
1. Study Identification
Unique Protocol Identification Number
NCT02127281
Brief Title
Evaluation of Wound Management With Negative Pressure Dressing Versus Standard Dressing After Revision Arthroplasty.
Official Title
Randomized Controlled Trial of Wound Management With Negative Pressure Dressing Versus Standard Dressing After Knee and Hip Revision Arthroplasty.
Study Type
Interventional
2. Study Status
Record Verification Date
August 2018
Overall Recruitment Status
Completed
Study Start Date
May 2014 (undefined)
Primary Completion Date
April 24, 2017 (Actual)
Study Completion Date
June 30, 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
The Cleveland Clinic
Collaborators
3M
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to determine the efficacy of a negative pressure wound therapy (NPWT) system after revision total knee and hip arthroplasty in patients at high risk for infection. It is hypothesized that the use of NPWT system (i.e., Prevena) in high risk patients prevents wound complications and decreases reoperation rates.
Detailed Description
One of the primary causes of un-planned readmission following lower extremity arthroplasty procedures is infection. Continuous wound drainage poses a serious risk for infection and is often initially treated with absorbent dressings and/or oral antibiotics. Comorbidities such as obesity, diabetes and tobacco abuse predisposes to wound complications and therefore infection after these procedures. NPWT has proven to be effective for postoperative drainage and decreases the risk for infection or further reoperation. This prospective randomized trial will involve 160 patients at high risk for infection undergoing revision total knee or hip arthroplasty; 80 patients will be randomly selected to be treated with the NPWT system (Prevena) and randomly selected to be treated with the current standard of care wound dressing (control group). Patients will be enrolled at a single site of the Cleveland Clinic Health System (Main Campus).
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Prosthesis-related Infections, Wound Complications, Joint Diseases, Musculoskeletal Diseases
Keywords
Revision total knee arthroplasty, Revision total hip arthroplasty, Negative pressure wound therapy system (NPWT), Drainage
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
160 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Prevena
Arm Type
Active Comparator
Arm Description
Prevena NPWT system will be used immediately following surgery and continue postoperatively until hospital discharge (expected average of 4 days).
Arm Title
Control
Arm Type
No Intervention
Arm Description
A standard of care sterile wound dressing will be placed.
Intervention Type
Device
Intervention Name(s)
Prevena
Intervention Description
Device will be applied at end of procedure over closed incision.
Primary Outcome Measure Information:
Title
Number of Patients With Wound Complications
Description
Any wound complications including but not limited to drainage, blisters, cellulitis, superficial infection, and deep infection.
Time Frame
Within 90 days after surgery
Title
Re-operation Rates
Description
Number of patients who required re-operations that were related to the revision arthroplasty and occurred within 90 days of the revision
Time Frame
Within 90 days after surgery
Title
Readmission Rates
Description
Number of patients who had hospital readmission(s) related to the revision surgery that occurred within 90 days of revision
Time Frame
Within 90 days after surgery
Secondary Outcome Measure Information:
Title
Knee Flexion
Description
Mean knee flexion (degrees) at 4 weeks postoperatively
Time Frame
4 weeks postoperative
Title
HOOS and KOOS Scores at 90 Days Postoperatively
Description
Mean Hip Osteoarthritis Outcome Score (HOOS), Knee Osteoarthritis Outcomes Score (KOOS) at 90 days postoperatively. Presented as subscores, including activities of daily living (ADL), pain, quality of life (QOL), symptoms, sports and recreation. All subscores range from 0-100, with 0 being the worst score and 100 being the best possible score.
Time Frame
90 days postoperative
Title
Timed-up-and-go Test
Description
Median Timed-up-and-go test (seconds)
Time Frame
4 weeks postoperatively
Title
Hip Range of Motion (Flexion)
Description
Mean hip range of motion (flexion, in degrees) at 4 weeks postoperatively
Time Frame
4 weeks postoperative
Title
VR-12 Questionnaire
Description
Mean VR-12 scores, presented as 2 composite scores physical component summary (PCS) and mental component summary (MCS). Physical Component Score (PCS): Provides greater emphasis on questions about general health, physical functioning and role playing and bodily pain. Mental Component Score (MCS): Provides greater emphasis on questions about role-emotional, vitality/mental health and social functioning. PCS and MCS summary scores are standardized using a z-score transformation and normed to a U.S. population (based on a 1990 norm) of a score of 50 and a standard deviation of 10. Higher MCS and PCS scores reflect better overall physical and mental health, respectively.
Time Frame
90 days postoperatively
Title
Hip Range of Motion
Description
Median hip range of motion (extension, in degrees) at 4 weeks postoperatively
Time Frame
4 weeks postoperative
Title
Knee Extension
Description
Median knee extension (degrees) at 4 weeks postoperatively
Time Frame
4 weeks postoperative
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Scheduled revision Total Hip or Knee Arthroplasty Procedure
Presence of one of the following: body mass index (BMI) greater than 35, use of blood thinners other than acetylsalicylic acid (ASA) after surgery, peripheral vascular disease, depression, diabetes mellitus, current tobacco use, history of prior infection, current use of immunomodulators or steroids, current history of cancer or hematological malignancy, rheumatoid arthritis, renal failure or dialysis, malnutrition, liver disease, transplant status, or HIV.
Exclusion Criteria:
Patient lives >100 miles from hospital
Patient is < 18 years old
Silver allergy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Carlos Higuera-Rueda, MD
Organizational Affiliation
The Cleveland Clinic
Official's Role
Principal Investigator
Facility Information:
Facility Name
Cleveland Clinic
City
Cleveland
State/Province
Ohio
ZIP/Postal Code
440195
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
23539123
Citation
Hansen E, Durinka JB, Costanzo JA, Austin MS, Deirmengian GK. Negative pressure wound therapy is associated with resolution of incisional drainage in most wounds after hip arthroplasty. Clin Orthop Relat Res. 2013 Oct;471(10):3230-6. doi: 10.1007/s11999-013-2937-3.
Results Reference
background
PubMed Identifier
19554385
Citation
Bozic KJ, Kurtz SM, Lau E, Ong K, Chiu V, Vail TP, Rubash HE, Berry DJ. The epidemiology of revision total knee arthroplasty in the United States. Clin Orthop Relat Res. 2010 Jan;468(1):45-51. doi: 10.1007/s11999-009-0945-0. Epub 2009 Jun 25.
Results Reference
background
Learn more about this trial
Evaluation of Wound Management With Negative Pressure Dressing Versus Standard Dressing After Revision Arthroplasty.
We'll reach out to this number within 24 hrs